Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing
/PRNewswire/ -- Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic...
Stay updated with breaking news from Arix Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic...
- The financing will support development of a commercial instrument system based on the company's proprietary and disruptive MAGNA technology. - MAGNA is set to unlock the field of dynamic
/PRNewswire/ -- Depixus®, a biotechnology company developing a unique technology for the fast, accurate, and straightforward extraction of multiomic...
Investegate announcements from Arix Bioscience PLC, Depixus raises €30.6M (£26.1 million) in Series A Financing
Disgraced fund manager continues to lay low as he seeks support for his latest venture far from home